Two professors in the Cancer Research Center (CRC) at The Alabama State University have been awarded pilot grants totaling ...

Using data from a large nationwide network of community-based health organizations, new study highlights critical shortfalls in cancer prevention care among patients who experience social and economic ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

Virginia G. Kaklamani, MD, DSc, discusses how effective elacestrant (Orserdu) is in CDK4/6 inhibitor-naive estrogen ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...

Imlunestrant, a next-generation SERD, improves progression-free survival in ER-positive advanced breast cancer patients ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced ...

Low-dose oral minoxidil (LDOM) is effective for alopecia in patients with breast cancer, according to a letter to th ...

Rosamund Dean, who was diagnosed with stage three breast cancer in 2019, has shared her experience of a 'crash menopause' ...